Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.

scientific article published on 17 July 2016

Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/14756366.2016.1193734
P932PMC publication ID6628712
P698PubMed publication ID27424662

P2093author name stringDominique Douguet
Philippe Diaz
Robert S Foti
P2860cites workMechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoproteinQ70884452
Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemiaQ71781078
Human cytochrome P-450 metabolism of retinals to retinoic acidsQ73462664
Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromesQ73462675
Extensive binding of the bioflavonoid quercetin to human plasma proteinsQ74410720
Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomesQ78251664
Use of an induced fit receptor structure in virtual screeningQ82621813
Homology models of human all-trans retinoic acid metabolizing enzymes CYP26B1 and CYP26B1 spliced variantQ84981035
Homology Models and Molecular Modeling of Human Retinoic Acid Metabolizing Enzymes Cytochrome P450 26A1 (CYP26A1) and P450 26B1 (CYP26B1)Q86833538
Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolismQ22254142
A Novel Human Cytochrome P450, CYP26C1, Involved in Metabolism of 9-cis and All-trans Isomers of Retinoic AcidQ24297212
Retinoic acid synthesis and signaling during early organogenesisQ24642848
Mechanisms of retinoic acid signalling and its roles in organ and limb developmentQ27014957
Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding siteQ27642793
Determinants of Cytochrome P450 2C8 Substrate Binding: STRUCTURES OF COMPLEXES WITH MONTELUKAST, TROGLITAZONE, FELODIPINE, AND 9-CIS-RETINOIC ACIDQ27650327
Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1Q28115020
Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cellsQ28115699
Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolitesQ28138601
Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylationQ28139603
CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new familyQ28244060
Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand bindingQ28270093
Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8Q28284393
Examination of 209 drugs for inhibition of cytochrome P450 2C8Q28298519
9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRαQ28343032
Characterization of three RXR genes that mediate the action of 9-cis retinoic acidQ28343068
Novel procedure for modeling ligand/receptor induced fit effects.Q30352584
Retinoic acid metabolism inhibition by 3-azolylmethyl-1H-indoles and 2, 3 or 5-(alpha-azolylbenzyl)-1H-indolesQ30732753
Cytochrome p450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapyQ30737013
A comparison of the roles of peroxisome proliferator-activated receptor and retinoic acid receptor on CYP26 regulationQ33613386
Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylaseQ33690947
Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factorQ33922396
Retinoids in embryonal developmentQ33967658
The relative importance of CYP26A1 in hepatic clearance of all-trans retinoic acidQ34005757
Clotrimazole: a review of its antifungal activity and therapeutic efficacyQ34022854
Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobioticsQ34345596
Quantifying and predicting the promiscuity and isoform specificity of small-molecule cytochrome P450 inhibitorsQ34359495
Retinoids for the treatment of psoriasis: outlook for the future.Q34379312
Clinical pharmacokinetics of candesartanQ34515194
Gemfibrozil greatly increases plasma concentrations of cerivastatinQ34530003
The role of vitamin A in mammalian reproduction and embryonic developmentQ34676020
Retinoid signalling in the development of the central nervous systemQ34988289
Retinoic acid metabolism and mechanism of action: a reviewQ35061108
Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylaseQ35122815
The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA PerspectiveQ35129048
Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylasesQ35589480
First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): identification of novel RAMBA scaffolds.Q35675265
CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukastQ35718619
Experimental studies with liarozole (R 75,251): an antitumoral agent which inhibits retinoic acid breakdownQ35834599
Cytochrome p450: a target for drug development for skin diseasesQ35860199
Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevanceQ36131028
Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype.Q36304459
Retinoic acid induces Sertoli cell paracrine signals for spermatogonia differentiation but cell autonomously drives spermatocyte meiosisQ36339894
Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesisQ36364699
Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases.Q36418564
Stereoselective formation and metabolism of 4-hydroxy-retinoic Acid enantiomers by cytochrome p450 enzymesQ36452010
RAR and RXR modulation in cancer and metabolic diseaseQ36956230
Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disordersQ36973819
Cytochrome P450s in the regulation of cellular retinoic acid metabolismQ37212128
The role of CYP26 enzymes in retinoic acid clearanceQ37313897
Human CYP2C8: structure, substrate specificity, inhibitor selectivity, inducers and polymorphismsQ37705508
The rhythm of retinoids in the brainQ38165261
Modulation of T cell and innate immune responses by retinoic AcidQ38198610
Differential contribution of active site residues in substrate recognition sites 1 and 5 to cytochrome P450 2C8 substrate selectivity and regioselectivityQ38340129
Quercetin pharmacokinetics in humansQ38502477
Design, synthesis, and biological evaluation of amide imidazole derivatives as novel metabolic enzyme CYP26A1 inhibitorsQ38964443
Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffoldQ39326501
Small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26): synthesis and biological evaluation of imidazole methyl 3-(4-(aryl-2-ylamino)phenyl)propanoatesQ39572100
Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cellsQ39947857
Expression of RALDHs (ALDH1As) and CYP26s in human tissues and during the neural differentiation of P19 embryonal carcinoma stem cellQ39978813
Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cellsQ40282939
The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancerQ40839068
Catalysis of the 4-hydroxylation of retinoic acids by cyp3a7 in human fetal hepatic tissues.Q40860308
Bioequivalence of two oral contraceptive drugs containing norethindrone and ethinyl estradiolQ41286094
Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agentsQ41648591
Catalytic versus inhibitory promiscuity in cytochrome P450s: implications for evolution of new functionQ41995930
Functional properties and substrate characterization of human CYP26A1, CYP26B1, and CYP26C1 expressed by recombinant baculovirus in insect cellsQ42726934
Benzbromarone Pharmacokinetics and Pharmacodynamics in Différent Cytochrome P450 2C9 GenotypesQ42852451
Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukastQ42997336
Relevance of nonsynonymous CYP2C8 polymorphisms to 13-cis retinoic acid and paclitaxel hydroxylation.Q43084915
Evaluation of CYP2C8 inhibition in vitro: utility of montelukast as a selective CYP2C8 probe substrateQ43503022
Antifungal triazoles induce malformations in vitroQ43698767
Role of retinoids in differentiation and carcinogenesis.Q43700097
Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acidsQ43930670
Cloning of rat cytochrome P450RAI (CYP26) cDNA and regulation of its gene expression by all-trans-retinoic acid in vivoQ44020686
Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemiaQ44449057
Gemfibrozil considerably increases the plasma concentrations of rosiglitazoneQ44536345
Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal spraysQ44870129
Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutantsQ45174835
Fluconazole alters CYP26 gene expression in mouse embryos.Q46017769
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazoneQ46496013
Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence.Q46497275
Retinoic acid in development: towards an integrated viewQ46549138
The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivoQ46664324
Effect of gemfibrozil on the pharmacokinetics of pioglitazoneQ46800471
The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspectiveQ47819795
Retinoid metabolism in the skin.Q47906563
Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzarone.Q51626478
Retinoic acid receptors: from molecular mechanisms to cancer therapy.Q52656210
Evaluation of cytochrome P450-mediated drug-drug interactions based on the strategies recommended by regulatory authorities.Q53203053
Dose-Dependent Interaction between Gemfibrozil and Repaglinide in Humans: Strong Inhibition of CYP2C8 with Subtherapeutic Gemfibrozil DosesQ57825122
Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamideQ57825160
Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymesQ59153155
The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukastQ60449842
Inhibition of retinoic acid metabolism by imidazole antimycotics in F9 embryonal carcinoma cellsQ69051552
Retinoic acid improves epidermal morphogenesisQ69075180
Second branchial arch anomalies induced by fluconazole, a bis-triazole antifungal agent, in cultured mouse embryosQ70675473
P433issuesup2
P921main subjecttretinoinQ29417
ligand bindingQ61659151
P304page(s)148-161
P577publication date2016-07-17
P1433published inJournal of Enzyme Inhibition and Medicinal ChemistryQ15708877
P1476titleComparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.
P478volume31